Cargando…
FGFR1, a novel biomarker for metastatic castration-resistant prostate cancer?
Autor principal: | Gallo, Leandro H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169064/ https://www.ncbi.nlm.nih.gov/pubmed/34084275 http://dx.doi.org/10.18632/oncotarget.27957 |
Ejemplares similares
-
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2021) -
Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer
por: Armstrong, K, et al.
Publicado: (2011) -
Resistance to Novel Antiandrogen Therapies in Metastatic
Castration-Resistant Prostate Cancer
por: Boudadi, Karim, et al.
Publicado: (2016) -
Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Liaw, Bobby C, et al.
Publicado: (2022) -
Enzalutamide for patients with metastatic castration-resistant prostate cancer
por: Ramadan, Wijdan H, et al.
Publicado: (2015)